Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Wu, Joseph C  [Clear All Filters]
2024
Chandy M, Hill T, Jimenez-Tellez N, Wu JC, S Sarles E, Hensel E, Wang Q, Rahman I, Conklin DJ. Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: "What Are the Tools Needed for the Job?" and "Do We Have Them?". Cardiovasc Toxicol. 2024.
Mullen MK, Kojic A, Alamana C, Canel G, Lai C, Knowles JW, Wu JC. Generation of two induced pluripotent stem cell lines from healthy patients of African American ancestry. Stem Cell Res. 2024;76:103322.
Cao X, Thomas D, Whitcomb LA, Wang M, Chatterjee A, Chicco AJ, Weil MM, Wu JC. Modeling ionizing radiation-induced cardiovascular dysfunction with human iPSC-derived engineered heart tissues. J Mol Cell Cardiol. 2024;188:105-107.
2023
Chandy M, Nishiga M, Wei T-T, Hamburg NM, Nadeau K, Wu JC. Adverse Impact of Cannabis on Human Health. Annu Rev Med. 2023.
Ramachandran A, Livingston CE, Vite A, Corbin EA, Bennett AI, Turner KT, Lee BW, Lam CKeung, Wu JC, Margulies KB. Biomechanical Impact of Pathogenic MYBPC3 Truncation Variant Revealed by Dynamically Tuning In Vitro Afterload. J Cardiovasc Transl Res. 2023.
Ahmed SMukhtar, Shivnaraine RV, Wu JC. FDA Modernization Act 2.0 Paves the Way to Computational Biology and Clinical Trials in a Dish. Circulation. 2023;148(4):309-311.
Zhang M, Venkateshappa R, Li A, Fowler MB, Telli ML, Wu JC. Generation and characterization of induced pluripotent stem cells from breast cancer patients carrying ATM mutations. Stem Cell Res. 2023;73:103246.
Zushin P-JH, Zhou Y, Li A, Ashley EA, Wheeler MT, Wu JC. Generation of two human iPSC lines with Exon 3 mutations in BCL2-Associated Athanogene 3 (BAG3) from dilated cardiomyopathy patients. Stem Cell Res. 2023;67:103019.
Zhang M, Liu W, Li A, Htet MH, Yu R, Telli ML, Wu JC. Generation of two induced pluripotent stem cell lines from breast cancer patients carrying BRCA2 variants. Stem Cell Res. 2023;72:103219.
Kong X, Belbachir N, Zeng W, Yan CD, Navada S, Perez MV, Wu JC. Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations. Stem Cell Res. 2023;69:103111.
Liu W, Zeng W, Kong X, Htet M, Yu R, Wheeler M, Day JW, Wu JC. Generation of two induced pluripotent stem cell lines from Duchenne muscular dystrophy patients. Stem Cell Res. 2023;72:103207.
Bonilauri B, Shin HSook, Htet M, Yan CD, Witteles RM, Sallam K, Wu JC. Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation. Stem Cell Res. 2023;72:103215.
Chen G, Orozco L, Parmisano S, Jahng JWS, Vera CD, Zhuge Y, Wu JC, Obal D. Generation of two induced pluripotent stem cell lines from patients suffering from pulmonary hypertension. Stem Cell Res. 2023;72:103218.
Zhu W, Liu W, Yu R, Manning M, Romfh AWaran, Wu JC. Generation of two induced pluripotent stem cell lines from patients with Down syndrome. Stem Cell Res. 2023;72:103204.
Seo K, Yamamoto Y, Kirillova A, Kawana M, Yadav S, Huang Y, Wang Q, Lane KV, Pruitt BL, Perez MV, et al. Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol. Circulation. 2023.
Shen M, Zhao SRui, Khokhar Y, Li L, Zhou Y, Liu C, Wu JC. Protocol to generate cardiac pericytes from human induced pluripotent stem cells. STAR Protoc. 2023;4(2):102256.
Guo H, Yu X, Liu Y, Paik DT, Justesen JMarie, Chandy M, Jahng JWS, Zhang T, Wu W, Rwere F, et al. SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common alcohol flushing variant. Sci Transl Med. 2023;15(680):eabp9952.
Liu C, Shen M, Tan WLW, Chen IY, Liu Y, Yu X, Yang H, Zhang A, Liu Y, Zhao M-T, et al. Statins improve endothelial function via suppression of epigenetic-driven EndMT. Nat Cardiovasc Res. 2023;2(5):467-485.
Shen M, Liu C, Zhao SRui, Manhas A, Sundaram L, Ameen M, Wu JC. Stepwise Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pericytes to Model Coronary Microvascular Dysfunction. Circulation. 2023;147(6):515-518.
Belbachir N, Wu Y, Shen M, Zhang SL, Zhang JZ, Liu C, Knollmann BC, Lyon GJ, Ma N, Wu JC. Studying Long QT Syndrome Caused by Genetic Variants Using Patient-Derived Induced Pluripotent Stem Cells. Circulation. 2023;148(20):1598-1601.
Tu C, Caudal A, Liu Y, Gorgodze N, Zhang H, Lam CKeung, Dai Y, Zhang A, Wnorowski A, Wu MA, et al. Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction. Nat Biomed Eng. 2023.
Eguchi A, Gonzalez AFernanda G, Torres-Bigio SI, Koleckar K, Birnbaum F, Zhang JZ, Wang VY, Wu JC, Artandi SE, Blau HM. TRF2 rescues telomere attrition and prolongs cell survival in Duchenne muscular dystrophy cardiomyocytes derived from human iPSCs. Proc Natl Acad Sci U S A. 2023;120(6):e2209967120.
2022
Chen SNee, Lam CKeung, Wan Y-W, Gao S, Malak OA, Zhao SRui, Lombardi R, Ambardekar AV, Bristow MR, Cleveland J, et al. Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy. Sci Adv. 2022;8(8):eabk0052.
Wei T-T, Chandy M, Nishiga M, Zhang A, Kumar KKrishna, Thomas D, Manhas A, Rhee S, Justesen JMarie, Chen IY, et al. Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation. Cell. 2022.
Roodgar M, Suchy FP, Nguyen LH, Bajpai VK, Sinha R, Vilches-Moure JG, Van Bortle K, Bhadury J, Metwally A, Jiang L, et al. Chimpanzee and pig-tailed macaque iPSCs: Improved culture and generation of primate cross-species embryos. Cell Rep. 2022;40(9):111264.

Pages